{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:10:24Z","timestamp":1790662224316,"version":"4.1.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG2E0371"],"award-info":[{"award-number":["CMRPG2E0371"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG2E0372"],"award-info":[{"award-number":["CMRPG2E0372"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG2E0373"],"award-info":[{"award-number":["CMRPG2E0373"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.01223","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T15:55:28Z","timestamp":1574438128000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer's Disease and Mild Cognitive Impairment"],"prefix":"10.3389","volume":"10","author":[{"given":"Wei-Chieh","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Yu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Hsing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/YCO.0b013e32816ebc7b","article-title":"The epidemiology of the dementias: an update","volume":"20","author":"Qiu","year":"2007","journal-title":"Curr Opin Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1212\/WNL.56.9.1133","article-title":"Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology","volume":"56","author":"Petersen","year":"2001","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/S0140-6736(06)68542-5","article-title":"Mild cognitive impairment","volume":"367","author":"Gauthier","year":"2006","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.dadm.2015.05.003","article-title":"The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment","volume":"1","author":"Klavins","year":"2015","journal-title":"Alzheimers Dement"},{"key":"B7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.dadm.2016.02.008","article-title":"Plasma phospholipids and prevalence of mild cognitive impairment and\/or dementia in the ARIC Neurocognitive Study (ARIC-NCS)","volume":"3","author":"Li","year":"2016","journal-title":"Alzheimers Dement"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-017-1297-5","article-title":"Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer's disease","volume":"14","author":"Marksteiner","year":"2018","journal-title":"Metabolomics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JAD-160172","article-title":"Targeted metabolomic analysis of soluble lysates from platelets of patients with mild cognitive impairment and alzheimer's disease compared to healthy controls: is PC aeC40:4 a promising diagnostic tool?","volume":"57","author":"Oberacher","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1038\/tp.2011.55","article-title":"Metabolome in progression to Alzheimer's disease","volume":"1","author":"Oresic","year":"2011","journal-title":"Transl Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"170140","DOI":"10.1038\/sdata.2017.140","article-title":"Targeted metabolomics and medication classification data from participants in the ADNI1 cohort","volume":"4","author":"St","year":"2017","journal-title":"Sci Data"},{"key":"B12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbacli.2015.11.004","article-title":"Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD)","volume":"5","author":"Wood","year":"2016","journal-title":"BBA Clin"},{"key":"B13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3233\/JAD-161226","article-title":"Diagnostic biomarkers of Alzheimer's disease as identified in saliva using 1H NMR-based metabolomics","volume":"58","author":"Yilmaz","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"10802","DOI":"10.1021\/ac3028307","article-title":"Development of isotope labeling LC-MS for human salivary metabolomics and application to profiling metabolome changes associated with mild cognitive impairment","volume":"84","author":"Zheng","year":"2012","journal-title":"Anal Chem"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0158000","DOI":"10.1371\/journal.pone.0158000","article-title":"Changes in the chemical barrier composition of tears in Alzheimer's disease reveal potential tear diagnostic biomarkers","volume":"11","author":"Kallo","year":"2016","journal-title":"PLoS ONE"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/elps.201300019","article-title":"Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients","volume":"34","author":"Tsuruoka","year":"2013","journal-title":"Electrophoresis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1586\/14737159.5.5.661","article-title":"CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment","volume":"5","author":"Blennow","year":"2005","journal-title":"Expert Rev Mol Diagn"},{"key":"B18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tibtech.2010.09.007","article-title":"Identifying and validating biomarkers for Alzheimer's disease","volume":"29","author":"Humpel","year":"2011","journal-title":"Trends Biotechnol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.cbpa.2004.08.013","article-title":"The role of analytical sciences in medical systems biology","volume":"8","author":"van der Greef","year":"2004","journal-title":"Curr Opin Chem Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fnins.2019.00343","article-title":"Metabolomics in the development and progression of dementia: a systematic review","volume":"13","author":"Jiang","year":"2019","journal-title":"Front Neurosci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"13764","DOI":"10.1038\/s41598-019-50205-0","article-title":"Targeted metabolomic analysis of nitric oxide\/L-arginine pathway metabolites in dementia: association with pathology, severity, and structural brain changes","volume":"9","author":"Fleszar","year":"2019","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fnagi.2019.00090","article-title":"Dysregulated urinary arginine metabolism in older adults with amnestic mild cognitive impairment","volume":"11","author":"Zhang","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jalz.2019.03.004","article-title":"Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort","volume":"15","author":"Kim","year":"2019","journal-title":"Alzheimers Dement"},{"key":"B24","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1532-5415.1992.tb01992.x","article-title":"The mini-mental state examination: a comprehensive review","volume":"40","author":"Tombaugh","year":"1992","journal-title":"J Am Geriatr Soc"},{"key":"B25","first-page":"637","article-title":"Clinical dementia rating (CDR)","volume":"24","author":"Berg","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"B26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1017\/S1041610294001602","article-title":"The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia","volume":"6","author":"Teng","year":"1994","journal-title":"Int Psychogeriatr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment","volume":"58","author":"Petersen","year":"2001","journal-title":"Arch Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/153331750502000502","article-title":"Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study","volume":"20","author":"Koontz","year":"2005","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"B29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/jnnp.2006.100529","article-title":"Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women","volume":"78","author":"Gustafson","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1212\/WNL.0b013e3182477eed","article-title":"Age and diagnostic performance of Alzheimer disease CSF biomarkers","volume":"78","author":"Mattsson","year":"2012","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3233\/JAD-121963","article-title":"Characteristic transformation of blood transcriptome in Alzheimer's disease","volume":"35","author":"Han","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jalz.2016.08.003","article-title":"Association of blood lipids with Alzheimer's disease: a comprehensive lipidomics analysis","volume":"13","author":"Proitsi","year":"2017","journal-title":"Alzheimers Dement"},{"key":"B34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"10761","DOI":"10.1073\/pnas.1402663111","article-title":"Effect of sleep deprivation on the human metabolome","volume":"111","author":"Davies","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12944-018-0665-0","article-title":"Lipidomic analysis of serum samples from migraine patients","volume":"17","author":"Ren","year":"2018","journal-title":"Lipids Health Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41387-017-0003-z","article-title":"Ethnic differences in metabolite signatures and type 2 diabetes: a nested case-control analysis among people of South Asian, African and European origin","volume":"7","author":"van Valkengoed","year":"2017","journal-title":"Nutr Diabetes"},{"key":"B38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0167-4838(01)00147-9","article-title":"Molecular enzymology of carnitine transfer and transport","volume":"1546","author":"Ramsay","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/db12-0466","article-title":"Acylcarnitines: reflecting or inflicting insulin resistance?","volume":"62","author":"Schooneman","year":"2013","journal-title":"Diabetes"},{"key":"B40","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.bbadis.2013.02.012","article-title":"Substrate specificity of human carnitine acetyltransferase: Implications for fatty acid and branched-chain amino acid metabolism","volume":"1832","author":"Violante","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3945\/jn.108.103754","article-title":"Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women","volume":"139","author":"Adams","year":"2009","journal-title":"J Nutr"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1194\/jlr.D061721","article-title":"An LC-MS\/MS method to quantify acylcarnitine species including isomeric and odd-numbered forms in plasma and tissues","volume":"56","author":"Giesbertz","year":"2015","journal-title":"J Lipid Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/msb.2012.43","article-title":"Novel biomarkers for pre-diabetes identified by metabolomics","volume":"8","author":"Wang-Sattler","year":"2012","journal-title":"Mol Syst Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S0891-5849(02)00824-9","article-title":"Protein turnover by the proteasome in aging and disease","volume":"32","author":"Shringarpure","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbapap.2004.08.010","article-title":"Methionine oxidation and aging","volume":"1703","author":"Stadtman","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"B46","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0070-2153(07)80003-2","article-title":"Substrates of the methionine sulfoxide reductase system and their physiological relevance","volume":"80","author":"Oien","year":"2008","journal-title":"Curr Top Dev Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","article-title":"Mitochondrial abnormalities in Alzheimer's disease","volume":"21","author":"Hirai","year":"2001","journal-title":"J Neurosci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/antiox7090122","article-title":"The functions of the mammalian methionine sulfoxide reductase system and related diseases","volume":"7","author":"Jiang","year":"2018","journal-title":"Antioxidants"},{"key":"B49","doi-asserted-by":"publisher","first-page":"001","DOI":"10.19080\/GJPPS.2017.02.555576","article-title":"Spermidine for a long, dementia-free life?","volume":"2","author":"Tsikas","year":"2017","journal-title":"Glob J Pharmaceu Sci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000364816","article-title":"Serum metabolomic biomarkers of dementia","volume":"4","author":"Mousavi","year":"2014","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1038\/s41598-019-40544-3","article-title":"Cerebrospinal fluid spermidine, glutamine and putrescine predict postoperative delirium following elective orthopaedic surgery","volume":"9","author":"Pan","year":"2019","journal-title":"Sci Rep"},{"key":"B52","first-page":"211","article-title":"L-arginine and Alzheimer's disease","volume":"2","author":"Yi","year":"2009","journal-title":"Int J Clin Exp Pathol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/JAD-2011-110405","article-title":"Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease","volume":"27","author":"Mielke","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neurobiolaging.2008.03.011","article-title":"Serum sphingomyelins and ceramides are early predictors of memory impairment","volume":"31","author":"Mielke","year":"2010","journal-title":"Neurobiol Aging"},{"key":"B55","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2217\/clp.12.59","article-title":"Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease?","volume":"7","author":"Mielke","year":"2012","journal-title":"Clin Lipidol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/0304-4165(79)90015-1","article-title":"N-delta-acetylornithine and S-methylcysteine in blood plasma","volume":"587","author":"Armstrong","year":"1979","journal-title":"Biochim Biophys Acta"},{"key":"B57","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nature10354","article-title":"Human metabolic individuality in biomedical and pharmaceutical research","volume":"477","author":"Suhre","year":"2011","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11481-015-9605-1","article-title":"Neurochemical metabolomics reveals disruption to sphingolipid metabolism following chronic haloperidol administration","volume":"10","author":"McClay","year":"2015","journal-title":"J Neuroimmune Pharmacol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1194\/jlr.M037622","article-title":"Alterations in cerebrospinal fluid glycerophospholipids and phospholipase A2 activity in Alzheimer's disease","volume":"54","author":"Fonteh","year":"2013","journal-title":"J Lipid Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/BF01001351","article-title":"Neurochemical aspects of Alzheimer's disease: involvement of membrane phospholipids","volume":"3","author":"Farooqui","year":"1988","journal-title":"Metab Brain Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/ijms14011310","article-title":"Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers","volume":"14","author":"Kosicek","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/BF02536067","article-title":"Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease","volume":"26","author":"Soderberg","year":"1991","journal-title":"Lipids"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3233\/JAD-142319","article-title":"Sphingomyelin SM(d18:1\/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-beta42, tau, and phospho-tau-181 levels","volume":"44","author":"Koal","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3389\/fneur.2017.00719","article-title":"Application of metabolomics in Alzheimer's disease","volume":"8","author":"Wilkins","year":"2017","journal-title":"Front Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01223\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T15:55:31Z","timestamp":1574438131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01223\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":64,"alternative-id":["10.3389\/fneur.2019.01223"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.01223","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"article-number":"1223"}}